Keynote 42: Pembrolizumab, PD-L1, and where to draw the line.

Ann Transl Med

Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA.

Published: April 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210198PMC
http://dx.doi.org/10.21037/atm.2020.01.65DOI Listing

Publication Analysis

Top Keywords

keynote pembrolizumab
4
pembrolizumab pd-l1
4
pd-l1 draw
4
keynote
1
pd-l1
1
draw
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!